14
Views
2
CrossRef citations to date
0
Altmetric
Articles

Allogeneic Peripheral Blood Stem Cell Transplantation: Is there an increased risk of graft vs host disease in leukemia patients?

Pages 371-376 | Published online: 18 Jul 2013

References

  • Russell NH, Hunter AE. Peripheral blood stem cells for allogeneic transplantation. Bone Marrow Transplant 1994; 13: 353–355.
  • Goldman J. Peripheral blood stem cells for allografting. Blood 1995; 85: 1413–1415.
  • Dreger P, Haferlach T, Eckstein V, et al. G-CSF mobilised peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilisation and composi-tion of the graft. Br J Haematol 1994; 87: 609–613.
  • Korbling M, Przepiorka D, Huh YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allo-grafts. Blood 1995; 85: 1659–1665.
  • Giirman G, Kahveci G, Akan H, et al. Allogeneic peripheral blood stem cell transplantation as a second trans-plant for severe aplastic anemia. Bone Marrow Transplant 1995; 15: 485.
  • Kessinger A, Smith DM, Strandjord SE, et al. Allogeneic transplantation of blood derived, Tcell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989; 4: 643–646.
  • Dreger P, Suttorp M, Haferlach T, Löffler H, Schmitz N, Schroyens W. Allogeneic granulocyte colony stimulating factor mobilised peripheral blood stem cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993; 81: 1404–1409.
  • Russell NH, Hunter A, Rogers S, Hanley J, Anderson D. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 1993; 341: 1482.
  • Russell NH, Pacey S. Economic evaluation of peripheral blood stem cell transplantation for lymphoma. Lancet 1992; 340: 1290.
  • Bensinger WI, Clift RA, Anasetti C, et al. Transplantation of allogeneic peripheral stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells 1996; 14: 90–105.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.